Skip to main content
Equibles

Michael

Analyst

Rothschild and Co. Redburn

Equibles does not estimate personal net worth.

About Michael

Michael is recorded as Analyst at Rothschild and Co. Redburn. Michael has spoken on 1 earnings call across 1 company, most recently for Novartis AG on October 27, 2026. The companies whose calls Michael spoke on are classified in the Healthcare sector.

Michael on recent calls

“Thank you very much for the commentary on the SG&A line in 3Q, and I appreciate the seasonality in 4Q, but I'm just wondering what the durability is of that cost reduction and how we should think about that line going forward.”
Analyst — Rothschild and Co. Redburn, Q3 FY2026 Earnings conference call (announced in 6-K) ·

Affiliation history

  • Rothschild and Co. Redburn

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity